Mehanna, R., Marras, C., Fleisher, J., Post, B., Kumar, K. R., Noyce, A., Alcalay, R., Morris, H. R., Hatano, T., Salari, M., Smilowska, K., Wu, Y. R., Zhang, B., Tan, E.-K., & Savica, R. (2025). Diagnostic work up when suspecting early onset Parkinson disease (EOPD). Recommendations from the MDS EOPD study group. Parkinsonism & Related Disorders, 135, 107852. https://doi.org/10.1016/j.parkreldis.2025.107852

Maayan Eshed, G., & Alcalay, R. N. (2025). Precision Medicine in Parkinson’s Disease. Neurologic Clinics, 43(2), 365–381. https://doi.org/10.1016/j.ncl.2024.12.011

Goldstein, O., Shani, S., Gana-Weisz, M., Elkoshi, N., Casey, F., Sun, Y. H., Chandratre, K., Cedarbaum, J. M., Blauwendraat, C., Bar-Shira, A., Thaler, A., Gurevich, T., Mirelman, A., Giladi, N., Orr-Urtreger, A., & Alcalay, R. N. (2025). The effect of polygenic risk score on PD risk and phenotype in LRRK2 G2019S and GBA1 carriers. Journal of Parkinson’s Disease. https://doi.org/10.1177/1877718x241310722

Williams, G. P., Freuchet, A., Michaelis, T., Frazier, A., Tran, N. K., Rodrigues Lima-Junior, J., Phillips, E. J., Mallal, S. A., Litvan, I., Goldman, J. G., Alcalay, R. N., Sidney, J., Sulzer, D., Sette, A., & Lindestam Arlehamn, C. S. (2024). PINK1 is a target of T cell responses in Parkinson’s disease. Journal of Clinical Investigation. https://doi.org/10.1172/jci180478

Shani, S., Gana-Weisz, M., Bar-Shira, A., Thaler, A., Gurevich, T., Mirelman, A., Giladi, N., Alcalay, R. N., Orr-Urtreger, A., & Goldstein, O. (2024). P2RX7, an adaptive immune response gene, is associated with Parkinson’s disease risk and age at onset. Journal of Parkinson’s Disease. https://doi.org/10.1177/1877718x241296015

Jones-Tabah, J., He, K., Karpilovsky, N., Senkevich, K., Deyab, G., Pietrantonio, I., Goiran, T., Cousineau, Y., Nikanorova, D., Goldsmith, T., del Cid Pellitero, E., Chen, C. X.-Q., Luo, W., You, Z., Abdian, N., Ahmad, J., Ruskey, J. A., Asayesh, F., Spiegelman, D., … Fon, E. A. (2024). The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons. Molecular Neurodegeneration, 19(1). https://doi.org/10.1186/s13024-024-00779-9

Curtis, J. A., Borders, J. C., Kiefer, B., Alcalay, R. N., Huber, J. E., & Troche, M. S. (2024). Respiratory–Swallow Coordination and Its Relationship With Pharyngeal Residue, Penetration, and Aspiration in People With Parkinson’s Disease. Journal of Speech, Language, and Hearing Research, 67(11), 4314–4338. https://doi.org/10.1044/2024_jslhr-24-00056

Gallagher, J., Gochanour, C., Caspell-Garcia, C., Dobkin, R. D., Aarsland, D., Alcalay, R. N., Barrett, M. J., Chahine, L., Chen-Plotkin, A. S., Coffey, C. S., Dahodwala, N., Eberling, J. L., Espay, A. J., Leverenz, J. B., Litvan, I., Mamikonyan, E., Morley, J., Richard, I. H., Rosenthal, L., … Razzaque, J. (2024). Long-Term Dementia Risk in Parkinson Disease. Neurology, 103(5). https://doi.org/10.1212/wnl.0000000000209699

Parrish, R. L., Buchman, A. S., Tasaki, S., Wang, Y., Avey, D., Xu, J., De Jager, P. L., Bennett, D. A., Epstein, M. P., & Yang, J. (2024). SR-TWAS: leveraging multiple reference panels to improve transcriptome-wide association study power by ensemble machine learning. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-50983-w

Cook, L., Verbrugge, J., Schwantes-An, T.-H., Schulze, J., Foroud, T., Hall, A., Marder, K. S., Mata, I. F., Mencacci, N. E., Nance, M. A., Schwarzschild, M. A., Simuni, T., Bressman, S., Wills, A.-M., Fernandez, H. H., Litvan, I., Lyons, K. E., Shill, H. A., Singer, C., … Alcalay, R. N. (2024). Parkinson’s disease variant detection and disclosure: PD GENEration, a North American study. Brain, 147(8), 2668–2679. https://doi.org/10.1093/brain/awae142

Barbuti, P. A. (2024). A-Syn(ful) MAM: A Fresh Perspective on a Converging Domain in Parkinson’s Disease. International Journal of Molecular Sciences, 25(12), 6525. https://doi.org/10.3390/ijms25126525

Zhao, Y., Lai, Y., Konijnenberg, H., Huerta, J. M., Vinagre-Aragon, A., Sabin, J. A., Hansen, J., Petrova, D., Sacerdote, C., Zamora-Ros, R., Pala, V., Heath, A. K., Panico, S., Guevara, M., Masala, G., Lill, C. M., Miller, G. W., Peters, S., & Vermeulen, R. (2024). Association of Coffee Consumption and Prediagnostic Caffeine Metabolites With Incident Parkinson Disease in a Population-Based Cohort. Neurology, 102(8). https://doi.org/10.1212/wnl.0000000000209201

Tuncer, T., Dogan, S., Baygin, M., Barua, P. D., Palmer, E. E., March, S., Ciaccio, E. J., Tan, R.-S., & Acharya, U. R. (2024). FLP: Factor lattice pattern-based automated detection of Parkinson’s disease and specific language impairment using recorded speech. Computers in Biology and Medicine, 173, 108280. https://doi.org/10.1016/j.compbiomed.2024.108280

Alessi, D. R., Cullen, P. J., Cookson, M., Merchant, K. M., & Small, S. A. (2024). Retromer-dependent lysosomal stress in Parkinson’s disease. Philosophical Transactions of the Royal Society B: Biological Sciences, 379(1899). https://doi.org/10.1098/rstb.2022.0376

Maayan Eshed, G., & Alcalay, R. N. (2024). GBA1-and LRRK2-directed Treatments: The Way Forward. Parkinsonism & Related Disorders, 122, 106039. https://doi.org/10.1016/j.parkreldis.2024.106039

Adkins-Jackson, P. B., Taikeff, N., Akingbulu, J., Avila-Rieger, J. F., & Corona-Long, C. A. (2024). Parkinson’s Disease Inequities in Daily Cognitive Activities: An Intersectional Approach. Ethnicity & Disease, 34(2), 113–122. https://doi.org/10.18865/ed.34.2.113

Shani, S., Gana-Weisz, M., Bar-Shira, A., Thaler, A., Gurevich, T., Mirelman, A., Giladi, N., Alcalay, R. N., Goldstein, O., & Orr-Urtreger, A. (2023). MAPT Locus in Parkinson’s Disease Patients of Ashkenazi Origin: A Stratified Analysis. Genes, 15(1), 46. https://doi.org/10.3390/genes15010046

Wang, Q., & Wang, Y. (2022). Multilayer Exponential Family Factor models for integrative analysis and learning disease progression. Biostatistics, 25(1), 203–219. https://doi.org/10.1093/biostatistics/kxac042

Keavney, J. L., Mathur, S., Schroeder, K., Merrell, R., Castillo-Torres, S. A., Gao, V., Crotty, G. F., Schwarzschild, M. A., & Poma, J. M. (2024). Perspectives of People At-Risk on Parkinson’s Prevention Research. Journal of Parkinson’s Disease, 14(3), 399–414. https://doi.org/10.3233/jpd-230436

Fernandez, H. H., Macklin, E. A., Hauser, R. A., Chou, K. L., Cakmak, Y. O., Ozsoy, B., & Fahn, S. (2024). Intrinsic auricular muscle zone stimulation for Parkinson disease: The EARSTIM-PD Phase II multi-center pilot study results. Parkinsonism & Related Disorders, 121, 105959. https://doi.org/10.1016/j.parkreldis.2023.105959

Kipnis, D., Pacheco, A., Delfing, D., Toomer-Mensah, N., Macpherson, C. E., Rieger, J., Parker, A., Coley, R. B., Coley, D., Shah, H., & Quinn, L. (2024). Community-based participatory research approach to address healthcare disparities confronting members of the Black Diaspora with Parkinson’s disease. Parkinsonism & Related Disorders, 119, 105936. https://doi.org/10.1016/j.parkreldis.2023.105936

Wang, Q., Tao, S., Xing, L., Liu, J., Xu, C., Xu, X., Ding, H., Shen, Q., Yu, X., & Zheng, Y. (2023). SNAP25 is a potential target for early stage Alzheimer’s disease and Parkinson’s disease. European Journal of Medical Research, 28(1). https://doi.org/10.1186/s40001-023-01360-8

Zhao, Y., Walker, D. I., Lill, C. M., Bloem, B. R., Darweesh, S. K. L., Pinto-Pacheco, B., McNeil, B., Miller, G. W., Heath, A. K., Frissen, M., Petrova, D., Sánchez, M.-J., Chirlaque, M.-D., Guevara, M., Zibetti, M., Panico, S., Middleton, L., Katzke, V., Kaaks, R., … Vermeulen, R. (2023). Lipopolysaccharide-binding protein and future Parkinson’s disease risk: a European prospective cohort. Journal of Neuroinflammation, 20(1). https://doi.org/10.1186/s12974-023-02846-2

Boruah, A. P., Thakur, K. T., Gadani, S. P., Kothari, K. U., Chomba, M., Guekht, A., Heydari, K., Hoo, F. K., Hwang, S., Michael, B. D., Pandit, M. V., Pardo, C. A., Prasad, K., Sardar, Z., Seeher, K., Solomon, T., Winkler, A. S., Wood, G. K., & Schiess, N. (2023). Pre-existing neurological conditions and COVID-19 co-infection: Data from systematic reviews, meta-analyses, and scoping reviews. Journal of the Neurological Sciences, 455, 120858. https://doi.org/10.1016/j.jns.2023.120858

Sun, J., Ludvigsson, J. F., Roelstraete, B., Pedersen, N. L., Pawitan, Y., Wirdefeldt, K., & Fang, F. (2022). Gastrointestinal biopsy of normal mucosa or nonspecific inflammation and risk of neurodegenerative disease: Nationwide matched cohort study. European Journal of Neurology, 30(11), 3430–3439. Portico. https://doi.org/10.1111/ene.15654

Garretti, F., Monahan, C., Sloan, N., Bergen, J., Shahriar, S., Kim, S. W., Sette, A., Cutforth, T., Kanter, E., Agalliu, D., & Sulzer, D. (2023). Interaction of an α-synuclein epitope with HLA-DRB1∗15:01 triggers enteric features in mice reminiscent of prodromal Parkinson’s disease. Neuron, 111(21), 3397-3413.e5. https://doi.org/10.1016/j.neuron.2023.07.015

Cook, L., Verbrugge, J., Schwantes-An, T.-H., Schulze, J., Beck, J. C., Naito, A., Hall, A., Chan, A. K., Casaceli, C. J., Marder, K., Nance, M., Schwarzschild, M. A., Simuni, T., Wills, A.-M., & Alcalay, R. N. (2023). Providing genetic testing and genetic counseling for Parkinson’s disease to the community. Genetics in Medicine, 25(10), 100907. https://doi.org/10.1016/j.gim.2023.100907

Senkevich, K., Beletskaia, M., Dworkind, A., Yu, E., Ahmad, J., Ruskey, J. A., Asayesh, F., Spiegelman, D., Fahn, S., Waters, C., Monchi, O., Dauvilliers, Y., Dupré, N., Greenbaum, L., Hassin‐Baer, S., Nagornov, I., Tyurin, A., Miliukhina, I., Timofeeva, A., … Gan‐Or, Z. (2023). Association of Rare Variants in ARSA with Parkinson’s Disease. Movement Disorders, 38(10), 1806–1812. Portico. https://doi.org/10.1002/mds.29521

Krellman, J. W., & Mercuri, G. (2023). Cognitive Interventions for Neurodegenerative Disease. Current Neurology and Neuroscience Reports, 23(9), 461–468. https://doi.org/10.1007/s11910-023-01283-1

Qi, R., Sammler, E., Gonzalez-Hunt, C. P., Barraza, I., Pena, N., Rouanet, J. P., Naaldijk, Y., Goodson, S., Fuzzati, M., Blandini, F., Erickson, K. I., Weinstein, A. M., Lutz, M. W., Kwok, J. B., Halliday, G. M., Dzamko, N., Padmanabhan, S., Alcalay, R. N., Waters, C., … Sanders, L. H. (2023). A blood-based marker of mitochondrial DNA damage in Parkinson’s disease. Science Translational Medicine, 15(711). https://doi.org/10.1126/scitranslmed.abo1557

Le Guen, Y., Luo, G., Ambati, A., Damotte, V., Jansen, I., Yu, E., Nicolas, A., de Rojas, I., Peixoto Leal, T., Miyashita, A., Bellenguez, C., Lian, M. M., Parveen, K., Morizono, T., Park, H., Grenier-Boley, B., Naito, T., Küçükali, F., Talyansky, S. D., … Tan, E.-K. (2023). Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes. Proceedings of the National Academy of Sciences, 120(36). https://doi.org/10.1073/pnas.2302720120

Giladi, N., Alcalay, R. N., Cutter, G., Gasser, T., Gurevich, T., Höglinger, G. U., Marek, K., Pacchetti, C., Schapira, A. H. V., Scherzer, C. R., Simuni, T., Minini, P., Sardi, S. P., & Peterschmitt, M. J. (2023). Safety and efficacy of venglustat in GBA1-associated Parkinson’s disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial. The Lancet Neurology, 22(8), 661–671. https://doi.org/10.1016/s1474-4422(23)00205-3

Saunders‐Pullman, R., Raymond, D., Ortega, R. A., Shalash, A., Gatto, E., Salari, M., Markgraf, M., Alcalay, R. N., Mascalzoni, D., Mencacci, N. E., Bonifati, V., Merello, M., Chung, S. J., Novakovic, I., Bardien, S., Pal, G., Hall, A., Hattori, N., Lynch, T., … Simuni, T. (2023). International Genetic Testing and Counseling Practices for Parkinson’s Disease. Movement Disorders, 38(8), 1527–1535. Portico. https://doi.org/10.1002/mds.29442

Pal, G., Cook, L., Schulze, J., Verbrugge, J., Alcalay, R. N., Merello, M., Sue, C. M., Bardien, S., Bonifati, V., Chung, S. J., Foroud, T., Gatto, E., Hall, A., Hattori, N., Lynch, T., Marder, K., Mascalzoni, D., Novaković, I., Thaler, A., … Klein, C. (2023). Genetic Testing in Parkinson’s Disease. Movement Disorders, 38(8), 1384–1396. Portico. https://doi.org/10.1002/mds.29500

Agin‐Liebes, J., Hickman, R. A., Vonsattel, J. P., Faust, P. L., Flowers, X., Utkina Sosunova, I., Ntiri, J., Mayeux, R., Surface, M., Marder, K., Fahn, S., Przedborski, S., & Alcalay, R. N. (2023). Patterns of TDP‐43 Deposition in Brains with LRRK2 G2019S Mutations. Movement Disorders, 38(8), 1541–1545. Portico. https://doi.org/10.1002/mds.29449

Di Maio, A., Nuzzo, T., Gilio, L., Serra, M., Buttari, F., Errico, F., De Rosa, A., Bassi, M. S., Morelli, M., Sasabe, J., Sulzer, D., Carta, M., Centonze, D., & Usiello, A. (2023). Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson’s disease patients. Neurobiology of Disease, 184, 106203. https://doi.org/10.1016/j.nbd.2023.106203

Outeiro, T. F., Alcalay, R. N., Antonini, A., Attems, J., Bonifati, V., Cardoso, F., Chesselet, M., Hardy, J., Madeo, G., McKeith, I., Mollenhauer, B., Moore, D. J., Rascol, O., Schlossmacher, M. G., Soreq, H., Stefanis, L., & Ferreira, J. J. (2023). Defining the Riddle in Order to Solve It: There Is More Than One “Parkinson’s Disease.” Movement Disorders, 38(7), 1127–1142. Portico. https://doi.org/10.1002/mds.29419

Goldstein, O., Gana-Weisz, M., Banfi, S., Nigro, V., Bar-Shira, A., Thaler, A., Gurevich, T., Mirelman, A., Giladi, N., Alcalay, R. N., & Orr-Urtreger, A. (2023). Novel variants in genes related to vesicle-mediated-transport modify Parkinson’s disease risk. Molecular Genetics and Metabolism, 139(2), 107608. https://doi.org/10.1016/j.ymgme.2023.107608

York, M. K., & Alcalay, R. N. (2023). Enough vs. More: Neuropsychological testing is more useful than genetic testing in the baseline evaluation of Parkinson disease. Parkinsonism & Related Disorders, 111, 105403. https://doi.org/10.1016/j.parkreldis.2023.105403

Shani, S., Goldstein, O., Gana-Weisz, M., Bar-Shira, A., Thaler, A., Gurevich, T., Mirelman, A., Giladi, N., Alcalay, R. N., & Orr-Urtreger, A. (2023). Variants in PSMB9 and FGR differentially affect Parkinson’s disease risk in GBA and LRRK2 mutation carriers. Parkinsonism & Related Disorders, 111, 105398. https://doi.org/10.1016/j.parkreldis.2023.105398

Senkevich, K., Zorca, C. E., Dworkind, A., Rudakou, U., Somerville, E., Yu, E., Ermolaev, A., Nikanorova, D., Ahmad, J., Ruskey, J. A., Asayesh, F., Spiegelman, D., Fahn, S., Waters, C., Monchi, O., Dauvilliers, Y., Dupré, N., Greenbaum, L., Hassin-Baer, S., … Gan-Or, Z. (2022). GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s disease. Brain, 146(5), 1859–1872. https://doi.org/10.1093/brain/awac413

Siderowf, A., Concha-Marambio, L., Lafontant, D.-E., Farris, C. M., Ma, Y., Urenia, P. A., Nguyen, H., Alcalay, R. N., Chahine, L. M., Foroud, T., Galasko, D., Kieburtz, K., Merchant, K., Mollenhauer, B., Poston, K. L., Seibyl, J., Simuni, T., Tanner, C. M., Weintraub, D., … Soto, C. (2023). Assessment of heterogeneity among participants in the Parkinson’s Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study. The Lancet Neurology, 22(5), 407–417. https://doi.org/10.1016/s1474-4422(23)00109-6

Blauwendraat, C., Tayebi, N., Woo, E. G., Lopez, G., Fierro, L., Toffoli, M., Limbachiya, N., Hughes, D., Pitz, V., Patel, D., Vitale, D., Koretsky, M. J., Hernandez, D., Real, R., Alcalay, R. N., Nalls, M. A., Morris, H. R., Schapira, A. H. V., Balwani, M., & Sidransky, E. (2023). Polygenic Parkinson’s Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease. Movement Disorders, 38(5), 899–903. Portico. https://doi.org/10.1002/mds.29342

Wilkins, K. B., Kehnemouyi, Y. M., Petrucci, M. N., Anderson, R. W., Parker, J. E., Trager, M. H., Neuville, R. S., Koop, M. M., Velisar, A., Blumenfeld, Z., Quinn, E. J., & Bronte‐Stewart, H. M. (2023). Bradykinesia and Its Progression Are Related to Interhemispheric Beta Coherence. Annals of Neurology, 93(5), 1029–1039. Portico. https://doi.org/10.1002/ana.26605

Vidyadhara, D. J., Somayaji, M., Wade, N., Yücel, B., Zhao, H., Shashaank, N., Ribaudo, J., Gupta, J., Lam, T. T., Sames, D., Greene, L. E., Sulzer, D. L., & Chandra, S. S. (2023). Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson’s disease. Cell Reports, 42(3), 112231. https://doi.org/10.1016/j.celrep.2023.112231

Hauser, R. A., LeWitt, P. A., Waters, C. H., Grosset, D. G., & Blank, B. (2023). The Clinical Development of Levodopa Inhalation Powder. Clinical Neuropharmacology, 46(2), 66–78. https://doi.org/10.1097/wnf.0000000000000540

Louis, E. D., Martuscello, R. T., Gionco, J. T., Hartstone, W. G., Musacchio, J. B., Portenti, M., McCreary, M., Kuo, S.-H., Vonsattel, J.-P. G., & Faust, P. L. (2023). Histopathology of the cerebellar cortex in essential tremor and other neurodegenerative motor disorders: comparative analysis of 320 brains. Acta Neuropathologica, 145(3), 265–283. https://doi.org/10.1007/s00401-022-02535-z

Buchman, A. S., Yu, L., Klein, H.-U., Zammit, A. R., Oveisgharan, S., Grodstein, F., Tasaki, S., Levey, A. I., Seyfried, N. T., & Bennett, D. A. (2022). Proteome-Wide Discovery of Cortical Proteins That May Provide Motor Resilience to Offset the Negative Effects of Pathologies in Older Adults. The Journals of Gerontology: Series A, 78(3), 494–503. https://doi.org/10.1093/gerona/glac105

Marras, C., Alcalay, R. N., Siderowf, A., & Postuma, R. B. (2023). Challenges in the study of individuals at risk for Parkinson disease. Precision Medicine in Neurodegenerative Disorders, Part I, 219–229. https://doi.org/10.1016/b978-0-323-85538-9.00014-6